LEONHARDT VENTURES NEWS
Leonhardt and Genovese File Patent for Bioelectric Control of CXCL5 a Potential Protector Against Artery Occlusion and Cancer Tumor Growth
Salt Lake City, Utah and Los Angeles, CA – December 19th, 2017 (PRBUZZ) — Leonhardt’s Launchpads, an organ regeneration innovation/startup accelerator, focused on developing novel therapeutics for the treatment of organ degeneration today announced that it has filed a...
VascuStim Announces Launch of Diabetic Ulcer Clinical Research Program
Multi-site, prospective studies, and a patient registry, to commence in multiple countries with a total of 150 patients to be enrolled - titled the HEAL Registry Study Salt Lake City, Utah and Playa Vista, CA - November 27th, 2017-- VascuStim, an emerging leader in...
Brief quick elevator pitches for startups in 2017 portfolio class of Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. in order of most likely to exit soonest to latest…
WARNING: These elevator pitches are brief and concise by nature. By being so brief appropriate risks are not conveyed in these short statements. These elevator pitches reflect only the most positive optimistic personal opinions of the startup founders. Full risk...
PressureStim a Leonhardt Ventures Co. Announces Licensing of Patent Portfolio for Bioelectric Blood Pressure Management from Neuro Code Tech Holdings LLC Expanding Its Intellectual Property Estate.
Press Release – Santa Monica, California and Albuquerque, New Mexico, September 22nd, 2017 – PressureStim, an emerging leader in bioelectric blood pressure management announced today that the Company has entered into an option agreement that leads to an exclusive...
Leonhardt Ventures Announces Launch of DentaCell Accelerator
Playa Vista, CA and Salt Lake City, Utah (PRBUZZ), October 23rd, 2017 - Leonhardt Ventures is excited to announce a new accelerator program focused on transforming innovation in dentistry - The DentaCell Accelerator. The DentaCell Accelerator is committed to inviting...
Leonhardt Team Launches InStim Bioelectric Customized Inflammation Control
InStim is designed to read real time inflammatory and anti-inflammatory cytokines in body organs and then adjust real time up or down cytokine levels to get inflammation in balance and under control to promote optimal healing and long term organ health and function....
First bioelectric cancer tumor therapy designed for early detection, personalized real time reading
First bioelectric cancer tumor therapy designed for early detection, personalized real time reading, customized communication jamming, stopping cell division, starving blood supply, changing surface protein expression to trigger immunotherapy, customized real time...
Leonhardt Startup CancerCell Expands IP Estate for Bioelectric Treatment of Cancer Tumors
Published: Oct 20, 2017 First bioelectric cancer tumor therapy designed for early detection, personalized real time reading, customized communication jamming, stopping cell division, starving blood supply, changing surface protein expression to trigger immunotherapy,...
Second Heart Assist Launches Series of Preclinical Development Studies at Tufts Medical Center
Published: Oct 20, 2017 Early development testing of innovative circulatory assist device results show promise Boston, Mass. and Salt Lake City, Utah - October 19th, 2017 (PRBUZZ)-- Second Heart Assist, Inc. today announced the first successful implant of its Second...
Bioleonhardt And Second Heart Assist To Present At Intl. Academy Of Cardiology World Congress Of Heart Disease July 14th-16th Vancouver
Published: Jul 13, 2017 Santa Monica, CA and Salt Lake City, UT (PRBUZZ) July 12th, 2017 - Leonhardt's Launchpads is pleased to announce a number its portfolio companies will be presenting at the upcoming International Academy of Cardiology World Congress of Heart...